ARTRYA Ltd (AYA) - Total Assets
Based on the latest financial reports, ARTRYA Ltd (AYA) holds total assets worth AU$92.19 Million AUD (≈ $65.23 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore AYA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
ARTRYA Ltd - Total Assets Trend (2019–2025)
This chart illustrates how ARTRYA Ltd's total assets have evolved over time, based on quarterly financial data. See AYA net assets for net asset value and shareholders' equity analysis.
ARTRYA Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
ARTRYA Ltd's total assets of AU$92.19 Million consist of 72.4% current assets and 27.6% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 47.9% |
| Accounts Receivable | AU$5.38 Million | 22.7% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$1.45 Million | 6.1% |
| Intangible Assets | AU$5.09 Million | 21.5% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how ARTRYA Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of ARTRYA Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ARTRYA Ltd's current assets represent 72.4% of total assets in 2025, a decrease from 99.7% in 2019.
- Cash Position: Cash and equivalents constituted 47.9% of total assets in 2025, down from 99.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 22.7% of total assets.
ARTRYA Ltd Competitors by Total Assets
Key competitors of ARTRYA Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UNIDOC HEALTH CORP.
F:L7T
|
Germany | €2.30 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
Doctor Care Anywhere Group Plc
AU:DOC
|
Australia | AU$15.02 Million |
|
Emyria Ltd
AU:EMD
|
Australia | AU$6.62 Million |
ARTRYA Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 37.11 | 6.79 | 12.46 |
| Quick Ratio | 37.11 | 6.79 | 12.46 |
| Cash Ratio | 0.00 | 5.10 | 0.00 |
| Working Capital | AU$83.88 Million | AU$8.64 Million | AU$13.26 Million |
ARTRYA Ltd - Advanced Valuation Insights
This section examines the relationship between ARTRYA Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.98 |
| Latest Market Cap to Assets Ratio | 19.39 |
| Asset Growth Rate (YoY) | 24.5% |
| Total Assets | AU$23.68 Million |
| Market Capitalization | $459.08 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values ARTRYA Ltd's assets at a significant premium (19.39x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: ARTRYA Ltd's assets grew by 24.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for ARTRYA Ltd (2019–2025)
The table below shows the annual total assets of ARTRYA Ltd from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$23.68 Million ≈ $16.75 Million |
+24.53% |
| 2024-06-30 | AU$19.01 Million ≈ $13.45 Million |
-42.54% |
| 2023-06-30 | AU$33.09 Million ≈ $23.41 Million |
-24.58% |
| 2022-06-30 | AU$43.87 Million ≈ $31.04 Million |
-15.99% |
| 2021-06-30 | AU$52.22 Million ≈ $36.95 Million |
+1866.60% |
| 2020-06-30 | AU$2.66 Million ≈ $1.88 Million |
+190.34% |
| 2019-06-30 | AU$914.54K ≈ $647.09K |
-- |
About ARTRYA Ltd
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more